In patients with CRC, a higher expression of human equilibrative nucleoside transporter 1 (hENT1) is associated with a worse prognosis [34], probably due to the greater uptake of other nucleosides that allow cell proliferation [19]. Here, SLC29A1 is linked to colorectal carcinoma.